Background: The opioid epidemic in the United States has resulted in an increased number
of drug-exposed infants who are at risk for developing neonatal abstinence syndrome …

Background Although clinicians have traditionally used the Finnegan Neonatal Abstinence
Scoring Tool to assess the severity of neonatal opioid withdrawal, a newer function-based …

There has been increasing emphasis on the importance of the development of self-
regulatory capacities of the individual as the cornerstone of development. The caregivers' …

Importance Knowledge of health outcomes among opioid-exposed infants is limited,
particularly for those not diagnosed with neonatal opioid withdrawal syndrome (NOWS) …

OBJECTIVES: To reduce average length of stay (ALOS) in infants with neonatal abstinence
syndrome (NAS) transferred to the inpatient floor from the mother-infant unit. Secondarily, we …

Objectives: Identify the etiology and epidemiology of neonatal abstinence syndrome.
Describe the typical presentation, evaluation options, and assessment tools for neonatal …

Objective To support hospitals in the Massachusetts PNQIN collaborative with adoption of
the ESC Neonatal Opioid Withdrawal Syndrome (NOWS) Care Tool© and assess NOWS …

Neonates exposed prenatally to opioids will often develop a collection of withdrawal signs
known as neonatal abstinence syndrome (NAS). The incidence of NAS has substantially …

Objective: The purpose of this study was to critically analyze the role of stigma in the care of
pregnant and parenting individuals with opioid use disorder (OUD) through the theoretical …

Background While use of prescription opioids and medication assisted therapy (MAT) for
opioid use disorder in pregnancy, as well as the incidence of neonatal opioid withdrawal …